4.7 Editorial Material

Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic

Journal

NEUROLOGY
Volume 94, Issue 22, Pages 949-952

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0000000000009507

Keywords

-

Ask authors/readers for more resources

The emergence of novel coronavirus 2019 (COVID-19)(1)and the subsequent pandemic present a unique challenge to neurologists managing patients with multiple sclerosis (MS) and related neuroinflammatory disorders, such as neuromyelitis spectrum disorder (NMOSD).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available